Highlights
NASDAQ: ALKS       Alkermes Plc
Last Price Today's Change   Day's Range   Trading Volume
57.69   +0.96 (1.69%)  56.89 - 58.21  383,176

Overview

Avg Volume (4 weeks):0
4 Weeks Range:55.06 - 61.80
52 Weeks Range:36.71 - 62.50
Average Price Target: 72.00
Price Target Upside/Downside: +14.31

Headlines



No recent Headlines for this stock.


Business Background

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.

  Be the first to like this.
 


 

4459  2643  565  656 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BAC 24.215+0.585 
 JNUG 4.368-0.882 
 BABY 40.85+0.25 
 AKS 6.49-0.63 
 NUGT 8.06-1.30 
 SPY 238.79+1.62 
 GDX 22.115-1.085 
 ABX 17.083-1.957 
 FCX 12.915+0.685 
 XLF 23.965+0.285 
Partners & Brokers